Search
According to the latest report from Precedence Research, the global digital health market size is expected to grow from $420.08 billion in 2025 to $1.171 trillion by 2035, with a CAGR of 10.8%. AI, telemedicine, and wearable devices are driving the wave of healthcare digitalization, with Europe leading the global market.
The life sciences industry is accelerating its transformation toward precision medicine and AI-driven R&D. This article analyzes the latest developments of companies such as GSK, Takeda, Vertex, Novartis, Dassault Systèmes, and BMS, exploring how strategic acquisitions, regulatory approvals, and AI infrastructure are jointly shaping the new landscape of global healthcare technology.
In 2026, the biotechnology sector is moving from promise to execution. AI-driven R&D, breakthroughs in gene editing, regulatory reforms, and global transactions are reshaping the life sciences landscape. This article examines 26 key trends, covering dimensions such as scientific innovation, emerging markets, policy changes, and business models.
In 2026, the biotech and life sciences industry reaches a critical turning point. From AI-driven drug discovery to clinical breakthroughs in gene editing, from regulatory reforms to global capital flows, these 26 trends are reshaping the future of medical innovation.
According to Market.us Media data, the global digital health market is expected to reach $2.19 trillion by 2034, with $287.8 billion in 2024, representing a compound annual growth rate of 22.5%. North America dominates the market, while Asia-Pacific is growing the fastest, with telemedicine, medical AI, and wearable devices becoming core drivers.
In 2026, the biotech and life sciences field reaches a critical turning point. AI and machine learning become R&D infrastructure, gene editing, synthetic biology, and microbiome therapies move toward clinical application, and global regulatory frameworks are being rapidly restructured. This article outlines 26 major trends, analyzing how technology, markets, capital, and policy are reshaping the healthcare innovation ecosystem.
Medical AI has moved from experimentation to clinical practice, but the practical application of diagnosis, treatment, and decision support still faces challenges in data, trust, and integration. This article reviews the current state and future trends.
This article reviews the important developments in the global medical technology sector during the third week of April 2025, covering financing, FDA approvals, clinical trials, and M&A collaborations, and analyzes the impact of technological trends such as neural interfaces, AI-assisted diagnosis, and leadless pacing on the industry.
The global life science tools market is being redefined by automation, data science, and precision medicine. Reports project the market will reach $455 million by 2034, with a compound annual growth rate of 10.36%.
AI is reshaping the healthcare industry, from diagnostic assistance to patient management, with technology implementation accelerating. This article analyzes key trends, market impacts, and future challenges.
Discuss the impact of AI on employment in the healthcare industry, analyzing which positions are at risk, which are safe, and the new opportunities created by AI.
Six biomedical startups from Taiwan, led by Startup Island TAIWAN, held over 100 one-on-one business meetings with global pharmaceutical companies, investors, and research institutions at the BIO 2026 International Convention. Focusing on cutting-edge fields such as AI-assisted diagnostics, antibody therapies, and organoid platforms, this marks the continuous rise of Taiwan's international influence in the medical technology industry.